NATH BIOGENES (INDIA)
|
NATH BIOGENES (INDIA) Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|
INCOME : | ||||
Gross Sales | ₹13,770,298 Cr | ₹12,391,533 Cr | ₹124 Cr | ₹124 Cr |
Sales | ₹13,770,298 Cr | ₹12,391,533 Cr | ₹124 Cr | ₹124 Cr |
Job Work/ Contract Receipts | - | - | - | - |
Processing Charges / Service Income | - | - | - | - |
Revenue from property development | - | - | - | - |
Other Operational Income | - | - | - | - |
Less: Excise Duty | - | - | - | - |
Net Sales | ₹13,770,298 Cr | ₹12,391,533 Cr | ₹124 Cr | ₹124 Cr |
EXPENDITURE : | ||||
Increase/Decrease in Stock | ₹-1,085,886 Cr | ₹-232,292 Cr | ₹-2.32 Cr | ₹-2.32 Cr |
Raw Material Consumed | ₹895,673 Cr | ₹611,041 Cr | ₹6.11 Cr | ₹6.11 Cr |
Opening Raw Materials | - | - | - | - |
Purchases Raw Materials | - | - | - | - |
Closing Raw Materials | - | - | - | - |
Other Direct Purchases / Brought in cost | ₹895,673 Cr | ₹611,041 Cr | ₹6.11 Cr | ₹6.11 Cr |
Other raw material cost | - | - | - | - |
Power & Fuel Cost | ₹42,932 Cr | ₹33,988 Cr | ₹0.34 Cr | ₹0.34 Cr |
Electricity & Power | ₹42,932 Cr | ₹33,988 Cr | ₹0.34 Cr | ₹0.34 Cr |
Oil, Fuel & Natural gas | - | - | - | - |
Coals etc | - | - | - | - |
Other power & fuel | - | - | - | - |
Employee Cost | ₹1,022,194 Cr | ₹921,421 Cr | ₹9.21 Cr | ₹9.21 Cr |
Salaries, Wages & Bonus | ₹957,330 Cr | ₹870,080 Cr | ₹8.70 Cr | ₹8.70 Cr |
Contributions to EPF & Pension Funds | ₹35,854 Cr | ₹29,126 Cr | ₹0.29 Cr | ₹0.29 Cr |
Workmen and Staff Welfare Expenses | ₹29,009 Cr | ₹22,215 Cr | ₹0.22 Cr | ₹0.22 Cr |
Other Employees Cost | - | - | - | - |
Other Manufacturing Expenses | ₹6,575,475 Cr | ₹5,522,794 Cr | ₹55 Cr | ₹55 Cr |
Sub-contracted / Out sourced services | - | - | - | - |
Processing Charges | ₹2,285,306 Cr | ₹1,554,088 Cr | ₹16 Cr | ₹16 Cr |
Repairs and Maintenance | ₹55,614 Cr | ₹47,366 Cr | ₹0.47 Cr | ₹0.47 Cr |
Packing Material Consumed | - | - | - | - |
Other Mfg Exp | ₹4,234,555 Cr | ₹3,921,340 Cr | ₹39 Cr | ₹39 Cr |
General and Administration Expenses | ₹474,710 Cr | ₹411,432 Cr | ₹4.11 Cr | ₹4.11 Cr |
Rent , Rates & Taxes | ₹105,860 Cr | ₹76,387 Cr | ₹0.76 Cr | ₹0.76 Cr |
Insurance | ₹19,804 Cr | ₹16,374 Cr | ₹0.16 Cr | ₹0.16 Cr |
Printing and stationery | ₹38,160 Cr | ₹8,296 Cr | ₹0.08 Cr | ₹0.08 Cr |
Professional and legal fees | ₹44,054 Cr | ₹38,499 Cr | ₹0.39 Cr | ₹0.39 Cr |
Traveling and conveyance | ₹177,269 Cr | ₹173,121 Cr | ₹1.73 Cr | ₹1.73 Cr |
Other Administration | ₹266,832 Cr | ₹271,876 Cr | ₹2.72 Cr | ₹2.72 Cr |
Selling and Distribution Expenses | ₹3,726,941 Cr | ₹3,440,334 Cr | ₹34 Cr | ₹34 Cr |
Advertisement & Sales Promotion | ₹315,524 Cr | ₹306,616 Cr | ₹3.07 Cr | ₹3.07 Cr |
Sales Commissions & Incentives | ₹367 Cr | ₹3,962 Cr | ₹0.04 Cr | ₹0.04 Cr |
Freight and Forwarding | ₹451,002 Cr | ₹395,216 Cr | ₹3.95 Cr | ₹3.95 Cr |
Handling and Clearing Charges | - | - | - | - |
Other Selling Expenses | ₹2,960,048 Cr | ₹2,734,540 Cr | ₹27 Cr | ₹27 Cr |
Miscellaneous Expenses | ₹128,385 Cr | ₹215,483 Cr | ₹2.16 Cr | ₹2.16 Cr |
Bad debts /advances written off | ₹35,476 Cr | ₹963 Cr | ₹0.01 Cr | ₹0.01 Cr |
Provision for doubtful debts | ₹30,012 Cr | ₹31,684 Cr | ₹0.32 Cr | ₹0.32 Cr |
Losson disposal of fixed assets(net) | ₹552 Cr | ₹2,888 Cr | ₹0.03 Cr | ₹0.03 Cr |
Losson foreign exchange fluctuations | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - |
Other Miscellaneous Expenses | ₹62,346 Cr | ₹179,949 Cr | ₹1.80 Cr | ₹1.80 Cr |
Less: Expenses Capitalised | - | - | - | - |
Total Expenditure | ₹11,780,424 Cr | ₹10,924,203 Cr | ₹109 Cr | ₹109 Cr |
Operating Profit (Excl OI) | ₹1,989,874 Cr | ₹1,467,330 Cr | ₹15 Cr | ₹15 Cr |
Other Income | ₹58,025 Cr | ₹90,801 Cr | ₹0.91 Cr | ₹0.91 Cr |
Interest Received | ₹1,181 Cr | ₹6,193 Cr | ₹0.06 Cr | ₹0.06 Cr |
Dividend Received | - | - | - | - |
Profit on sale of Fixed Assets | ₹586 Cr | ₹1,478 Cr | ₹0.02 Cr | ₹0.02 Cr |
Profits on sale of Investments | - | - | - | - |
Provision Written Back | ₹1,639 Cr | ₹54,806 Cr | ₹0.55 Cr | ₹0.55 Cr |
Foreign Exchange Gains | - | - | - | - |
Others | ₹54,618 Cr | ₹28,324 Cr | ₹0.28 Cr | ₹0.28 Cr |
Operating Profit | ₹2,047,899 Cr | ₹1,558,131 Cr | ₹16 Cr | ₹16 Cr |
Interest | ₹367,298 Cr | ₹180,633 Cr | ₹1.81 Cr | ₹1.81 Cr |
InterestonDebenture / Bonds | - | - | - | - |
Interest on Term Loan | - | - | - | - |
Intereston Fixed deposits | - | - | - | - |
Bank Charges etc | ₹30,993 Cr | ₹8,250 Cr | ₹0.08 Cr | ₹0.08 Cr |
Other Interest | ₹336,304 Cr | ₹172,382 Cr | ₹1.72 Cr | ₹1.72 Cr |
PBDT | ₹1,680,601 Cr | ₹1,377,499 Cr | ₹14 Cr | ₹14 Cr |
Depreciation | ₹450,988 Cr | ₹469,996 Cr | ₹4.70 Cr | ₹4.70 Cr |
Profit Before Taxation & Exceptional Items | ₹1,229,613 Cr | ₹907,503 Cr | ₹9.08 Cr | ₹9.08 Cr |
Exceptional Income / Expenses | - | - | - | - |
Profit Before Tax | ₹1,229,613 Cr | ₹907,503 Cr | ₹9.08 Cr | ₹9.08 Cr |
Provision for Tax | ₹55,044 Cr | ₹-12,561 Cr | ₹-0.13 Cr | ₹-0.13 Cr |
Current Income Tax | ₹10,351 Cr | ₹5,500 Cr | ₹0.06 Cr | ₹0.06 Cr |
Deferred Tax | ₹-4,056 Cr | ₹-18,767 Cr | ₹-0.19 Cr | ₹-0.19 Cr |
Other taxes | ₹48,750 Cr | ₹706 Cr | ₹0.01 Cr | ₹0.01 Cr |
Profit After Tax | ₹1,174,569 Cr | ₹920,064 Cr | ₹9.20 Cr | ₹9.20 Cr |
Extra items | - | - | - | - |
Minority Interest | - | - | - | - |
Share of Associate | - | - | - | - |
Other Consolidated Items | - | - | - | - |
Consolidated Net Profit | ₹1,174,569 Cr | ₹920,064 Cr | ₹9.20 Cr | ₹9.20 Cr |
Adjustments to PAT | - | - | - | - |
Profit Balance B/F | ₹1,411,439 Cr | ₹491,375 Cr | ₹4.91 Cr | ₹4.91 Cr |
Appropriations | ₹2,586,009 Cr | ₹1,411,439 Cr | ₹14 Cr | ₹14 Cr |
General Reserves | - | - | - | - |
Proposed Equity Dividend | - | - | - | - |
Corporate dividend tax | - | - | - | - |
Other Appropriation | - | - | - | - |
Equity Dividend % | - | - | - | - |
Earnings Per Share | ₹7.34 | ₹5.75 | ₹5.75 | ₹5.75 |
Adjusted EPS | ₹7.34 | ₹5.75 | ₹5.75 | ₹5.75 |
Compare Income Statement of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹363.0 Cr | 0.8% | -15.2% | 27.9% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹10,454.3 Cr | 1.9% | -9.3% | 86.3% | Stock Analytics | |
KAVERI SEED COMPANY | ₹3,894.7 Cr | -1.5% | -5.4% | 22.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,469.8 Cr | -0.4% | -13.5% | -1.3% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹2,325.9 Cr | NA | -11.6% | -31.3% | Stock Analytics | |
TIERRA AGROTECH | ₹468.0 Cr | 3.7% | -21.5% | -47.8% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 0.8% |
-15.2% |
27.9% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses